Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-1831
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern ; volume:210 ; number:5-6 ; day:20 ; month:8 ; year:2021 ; pages:263-275 ; date:12.2021
Medical microbiology and immunology ; 210, Heft 5-6 (20.8.2021), 263-275, 12.2021

Creator
Osterman, Andreas
Iglhaut, Maximilian
Lehner, Andreas
Späth, Patricia
Stern, Marcel
Autenrieth, Hanna
Muenchhoff, Maximilian
Graf, Alexander
Krebs, Stefan
Blum, Helmut
Baiker, Armin
Grzimek-Koschewa, Natascha
Protzer-Knolle, Ulrike
Kaderali, Lars
Baldauf, Hanna-Mari
Keppler, Oliver Till
Contributor
SpringerLink (Online service)

DOI
10.1007/s00430-021-00719-0
URN
urn:nbn:de:101:1-2022010318353018592837
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:39 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Osterman, Andreas
  • Iglhaut, Maximilian
  • Lehner, Andreas
  • Späth, Patricia
  • Stern, Marcel
  • Autenrieth, Hanna
  • Muenchhoff, Maximilian
  • Graf, Alexander
  • Krebs, Stefan
  • Blum, Helmut
  • Baiker, Armin
  • Grzimek-Koschewa, Natascha
  • Protzer-Knolle, Ulrike
  • Kaderali, Lars
  • Baldauf, Hanna-Mari
  • Keppler, Oliver Till
  • SpringerLink (Online service)

Other Objects (12)

A comparison of transmissibility of SARS-CoV-2 variants of concern

A comparison of transmissibility of SARS-CoV-2 variants of concern

Emerging SARS-CoV-2 variants of concern and potential intervention approaches

Emerging SARS-CoV-2 variants of concern and potential intervention approaches

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern

Health system impacts of SARS-CoV − 2 variants of concern: a rapid review

Health system impacts of SARS-CoV − 2 variants of concern: a rapid review

Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance

Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance

Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis

Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern

SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization

SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization

Related objects